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Primary hyperparathyroidism may cause fetal demise in pregnant patients if prompt diagnosis and treatment is not initiated. The
paper describes a novel guide wire technique for a targeted parathyroidectomy, which may reduce the risk to mother and fetus and
be useful in other related circumstances.
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1.Introduction
Primary hyperparathyroidism is rare in pregnancy, but
the disease causes fetal demise if prompt diagnosis and
eﬀective management are not pursued. Previous studies have
demonstrated that eighty-one percent of cases of primary
hyperparathyroidism during pregnancy are caused by an
adenoma, twelve percent by parathyroid carcinoma, and the
remainder by hyperplasia [1, 2]. Maternal hypocalcemia in
the mother is caused by a physiologic state of gestational
hypoalbuminemia as well as a gradual increase in demand
for calcium by the fetus [3].
In mothers with primary hyperparathyroidism, the
increase in calcium levels suppresses fetal parathyroid devel-
opment, ultimately leading to hypocalcemia in the neonate.
Primary hyperparathyroidism has also been shown to be
associated with spontaneous abortion, stillbirth, neonatal
tetany, and intrauterine growth retardation.
Primary hyperparathyroidism is a diﬃcult diagnosis to
make during pregnancy because of its low clinical incidence,
clinical variability, and the diﬃcult in applying speciﬁc
instrumental exams. The gold standard for preoperative
localization during pregnancy is ultrasonography of the
neck, which has a sixty-nine percent sensitivity and ninety-
fourpercentspeciﬁcity.Computerizedtomography,parathy-
roid scintigraphy, and magnetic resonance imaging are also
useful, but are not typically used due to potential risks to the
fetus [4].
It is essential for surgeons to minimize the opera-
tion and anesthesia used in the treatment of primary
hyperparathyroidism. This paper describes a novel guide
wire technique, which provides targeted parathyroidectomy,
thereby potentially reducing the risk to mother and fetus and
selected others at high risk.
2.CaseReport
A 30-year-old African-American female was referred during
her second trimester of pregnancy for surgical management
of persistent primary hyperparathyroidism. The patient had
a history of multiple episodes of acute pancreatitis requiring
more than twenty hospitalizations for the treatment of that
condition. She also had a history of nephrolithiasis, but no
personal or family history of MEN syndromes and was nor-
motensive. Prior to her pregnancy, the patient had initially
underwent a neck exploration for what was diagnosed as
primary hyperparathyroidism at another institution, which
was unsuccessful in ﬁnding the abnormal parathyroid gland.
The operative report from the ﬁrst surgery was reviewed.
The surgeon who performed the ﬁrst operation extensively
described a thorough dissection during the ﬁrst operation.2 International Journal of Otolaryngology
The dissection included bilateral neck exploration, opening
both carotid sheaths, and intraoperative selective venous
sampling. The patient continued to have evidence of hyper-
calcemia postoperatively due to persistent primary hyper-
parathyroidism, with a serum level of calcium of 11mg/dL,
albuminof3.6g/dL,andanintactparathyroidhormonelevel
of 140pg/mL. The rest of her blood laboratory workup was
within normal limits. The preoperative localization workup
was performed at Tulane University Hospital and included
a repeat neck ultrasound that revealed a 1.0cm previously
missed hypoechoic mass in the tracheo-esophageal groove.
CT scanning was not utilized because of the risk to the fetus.
Due to the previous failed detailed dissection, the needle
localization technique was chosen for this pregnant patient.
This technique oﬀered a targeted focused approach without
the need for bilateral neck exploration. After obtaining
informed consent from the patient, the skin was prepped
in the standard fashion and local anesthesia administered.
A Homer needle was introduced under ultrasound guidance
and the tip guided to an appropriate position within the
mass. A 22-gauge Chiba needle was passed in a tandem fash-
ionandaspirationofthelesionwasattempted.Thespecimen
obtained was sent for intact PTH assay. Subsequently, 0.5mL
of methylene blue was instilled through the Homer needle.
Under ultrasound guidance, a hook wire was passed through
the Homer needle, conﬁrming placement of the wire tip
within the lesion. Both the Homer needle and wire were left
in place and secured, and the wire was taped in place. The
patient was then taken directly to the operating room.
The neck was prepped and draped in the standard
fashion, including the localization wire. Surgical exploration
was done under general anesthesia. A small skin incision
was made which included the point of entry of the guide
wire (Figure 1), and the wire was followed with meticulous
dissection and guidance by the presence of methylene blue
until the parathyroid adenoma was identiﬁed. All the tissue
impregnatedwithmethylenebluewasexcised,alongwiththe
masscontainingthehookwire.PTHserumlevels,monitored
intraoperatively, decreased from 143 to 23.6pg/mL after ten
minutes following the removal of the mass. This signiﬁcant
drop conﬁrmed the surgical correction of her disease and
eliminated the possibility of hyperplasia. The procedure
was done in seventy-ﬁve minutes including the waiting
time for reporting the results of the intraoperative PTH
assays monitoring. The patient tolerated the procedure
well. Throughout the procedure, the fetus showed good
movements by ultrasound. The patient did well and was
discharged home the next day. The patient’s postoperative
course was uneventful and she has maintained normocal-
cemia for six months postoperatively.
3. Discussion
Primary hyperparathyroidism is a relatively common disease
with an incidence of 0.1% to 0.2% in the general population.
This disease occurs in all ages, but most commonly in the
sixth decade of life with a three-to-one female-to-male ratio.
Benign adenomas are found in approximately eighty percent
of patients, and ﬁfteen to twenty percent of cases are due to
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Figure 1: (a) Ultrasound of parathyroid adenoma. (b) Same
patient, with guide wire in place (white dot).
hyperplasia. The most uncommon presentation of primary
hyperparathyroidism is parathyroid cancer, which is found
in only 0.5% of cases [1].
Complications, including hyperemesis and nephrolithiq-
sis, occur in sixty-seven percent of pregnant females diag-
nosed with primary hyperparathyroidism [3, 5, 6].
More severe maternal complications, such as pancreatitis
and hypercalcemic crisis, may also occur in the mother,
resulting in fetal growth retardation [5, 7–9]. Other com-
plications include spontaneous abortion, maternal death,
induced labor, intrauterine growth restriction, low birth
weight, and neonatal hypocalcemia [7, 10, 11].
Themostseriouscomplicationinprimaryhyperparathy-
roidism in pregnant women is hypercalcemic crisis, deﬁned
as a serum calcium level of >14mg/dL. This entity presents
with severe nausea, vomiting, dehydration, weakness, mental
status changes, with a rapid progression to uremia, coma,
and death. This complication may occur during the postpar-
tum period when the placenta is no longer shunting calcium
to the fetus [3].
Inuntreatedpatients,theincidenceoffetalcomplications
h a sb e e nr e p o r t e dt ob ea sh i g ha se i g h t yp e r c e n t .I nt r e a t e d
patients, the incidence of neonatal complications is ﬁfty-
three percent. Twenty-seven percent to thirty-one percent of
cases result in neonatal death [10, 11].International Journal of Otolaryngology 3
Parathyroidectomy is the best therapeutic option for
pregnant patients in the ﬁrst two trimesters. A recent
report advocated routine use of the parathyroid aspiration
technique for suspected intrathyroidal parathyroid tumors
and in ambiguous situations when the identity of the
parathyroid gland is in doubt [12].
In the patient described, parathyroidectomy with a guide
wire technique was performed in the second trimester with
nomaternalorfetalcomplications.Ascomparedtotheother
trimesters, anesthesia risks to infant and pregnant patients
are decreased once in the second trimester. Norman and
colleagues reported their experience over a period of six
years on thirty-two women with sporadic primary hyper-
parathyroidism with seventy-seven pregnancies. Primary
hyperparathyroidism was associated with 3.5 fold increase
in miscarriage rates. Thus, parathyroidectomy should be
oﬀeredinearlyinthesecondtrimester,resultingindecreased
future maternal and fetal complications [13].
While the traditional approach has been bilateral neck
exploration with identiﬁcation of all parathyroid tissue, the
recent literature has described numerous beneﬁts of targeted
parathyroidectomy, including decreased risk of nerve injury
and better cosmesis [14, 15]. These data, together with some
studies suggesting shorter operative times and lower cost
with equivalent results, make techniques facilitating focused
parathyroidectomyextremelyattractive.Thispaperdescribes
anovel,highlysuccessfulmethodofpreoperativelocalization
suitable for focused parathyroidectomy [16].
The beneﬁts of this technique are apparent. The high
degree of accuracy aﬀorded by ultrasonographic examina-
tion immediately prior to surgery allows accurate placement
of the needle, and then guide wire. Only four similar cases
have been described where wire and needle localization was
used for surgery, however, all of them utilized CT guidance
[17–20]. The overall technique was similar, using image-
guidance to precisely place a guide wire into the target
lesion closely associated with surrounding structures. The
possibility of spread of parathyroid tissue was considered,
butthereisnocurrentevidencethatrecurrenthyperparathy-
roidism has been caused by penetration of an adenoma with
a needle. Despite long-term follow-up, needle aspiration has
become a standard technique. The ability to follow the wire
intraoperatively avoids unnecessary trauma to these other
structures from blind dissection, and may alleviate the need
for an extensive operation.
This Technique is not necessary for all reoperative
parathyroid explorations for recurrent or persistent disease.
It was selected speciﬁcally for use in these unusual circum-
s t a n c e s .I ti sd e s c r i b e da sa ne ﬀective technique for selected
high-risk patients.
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